Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discovery of New Biomarkers in Pancreatic Cancer Using Novel Nondestructive OMICS Methodology

NCT03791073 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03791073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03791073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discovery of New Biomarkers in Pancreatic Cancer Using Novel Nondestructive OMICS Methodology
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2018
Completion date
November 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oncology